REFERENCES
M. Czupryn, F. Bennett, J. Dube, K. Grant, H. Scoble, H. Sookdeo, and J. M. McCoy. Alanine-scanning mutagenesis of human interleuken 11: identification of regions important for biological activity. Ann. N. Y. Acad. Sci. 762:152–164 (1995).
S. J. Goldman. Preclinical biology of interleukin 11: a multifunctional hematopoietic cytokine with potent thrombopoietic activity. Stem Cells (Dayt) 13:462–471 (1995).
R. L. Peterson, L. Wang, L. Albert, J. C. Keith, Jr., and A. J. Dorner. Molecular effects of recombinant human interleukin-11 in the HLA-B27 rat model of inflammatory bowel disease. Lab. Invest. 78:1503–1512 (1998).
W. L. Trepicchio, M. Bozza, G. Pedneault and A. J. Dorner. Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production. J. Immunol. 157:3627–3634 (1996).
A. Takagi, H. Masuda, Y. Takakura, and M. Hashida. Disposition characteristics of recombinant human interleukin-11 after a bolus intravenous administration in mice. J. Pharmacol. Exp. Ther. 275:537–543 (1995).
T. Uchida, K. Aoyama, K. Mori, T. Usui, T. Watanabe, Y. Takariki, N. Asahara, M. Hirose, T. Kimura, M. Tateishi, and S. Higuchi. Pharmacokinetics of [125I]-recombinant human interleukin-11:1 Absorption, distribution and excretion after subcutaneous administration to male rats. Eur. J. Drug Metab. Pharmacokinet. 23: 403–410 (1998).
K. Aoyama, T. Uchida, F. Takanuki, T. Usui, T. Watanabe, S. Higuchi, T. Toyoki, and H. Mizoguchi. Pharmacokinetics of recombinant human inteleukin-11 (rhIL-11) in healthy male subjects. Br. J. Clin. Pharmacol. 43:571–578 (1997).
D. J. Hnatowich, W. W. Layne, and R. L. Childs. The preparation and labeling of DTPA-coupled albumin. Int. J. Appl. Radiat. Isot. 33:327–332 (1982).
H. Baumann, and J. Gauldie. The acute phase response [see comments]. Immunol. Today 15:74–80 (1994).
S. Neben, and K. Turner. The biology of interleukin 11. Stem Cells (Dayt) 11 Suppl 2: 156–162 (1993).
M. S. Gordon, W. J. McCaskill-Stevens, L. A. Battiato, J. Loewy, D. Loesch, E. Breeden, R. Hoffman, K. J. Beach, B. Kuca, J. Kaye, and G. W. Sledge, Jr. A phase I trial of recombinant human inteleukin-11 (neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy. Blood 87:3615–3624 (1996).
C. Gabay, and I. Kushner. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340:448–454 (1999).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tseng, CM.L., Albert, L., Peterson, R.L. et al. In Vivo Absorption Properties of Orally Administered Recombinant Human Interleukin-11. Pharm Res 17, 482–485 (2000). https://doi.org/10.1023/A:1007545524408
Issue Date:
DOI: https://doi.org/10.1023/A:1007545524408